Auxilius names Holly Leslie vice president of investigator grant solutions

Auxilius appointed life sciences veteran Holly Leslie as vice president, Investigator Grant Solutions, to help biotech and pharma sponsors better forecast, manage and reconcile clinical trial grants. The move signals a push to deepen the company’s platform and connect clinical operations with financial oversight.

Why it matters: - Auxilius is betting on experienced leadership to strengthen a core part of its clinical trial financial management platform. - Better investigator grant planning and reconciliation can help sponsors reduce friction between clinical operations, finance and site engagement. - The hire fits a broader push to connect trial execution data with financial intelligence.

What happened: - Auxilius named Holly Leslie vice president, Investigator Grant Solutions. - Leslie will lead product strategy, go-to-market execution and stakeholder engagement. - The role is designed to bridge clinical operations and financial intelligence for biotech and pharma sponsors.

The details: - Leslie brings more than 20 years of experience across sponsor organizations, CROs and clinical software platforms. - Her background includes leadership roles at Wyeth, now Pfizer, CFS Clinical, Medidata and LedgerRun. - Auxilius said Leslie will oversee solutions that help sponsors forecast, manage and reconcile investigator grants. - Leslie said clinical study management systems remain siloed, which makes it hard for sponsors, sites and CROs to connect daily operations with financial oversight. - Leslie said Auxilius offers a unified view by combining enrollment tracking, financial forecasting and accounting insights into one source of truth. - Leslie said the company’s goal is to help clinical trial sites function as true research partners rather than isolated vendors. - Leslie said her interest in clinical research was shaped by her mother’s glioblastoma diagnosis in 1994 and participation in a clinical trial. - Leslie described her career goal as “leave it better than you found it.” - Leslie will also focus on helping life sciences organizations adopt modern data analytics and pragmatic technology. - Leslie said automation works best when it removes routine administrative burdens so teams can focus on higher-value decisions. - Auxilius CEO Adam Weisman said Leslie’s experience across site engagement, financial management and investigator grants will help the company expand platform capabilities.

Between the lines: - Auxilius is signaling that investigator grant management is not just an operational function but a strategic lever for platform growth. - The hire also suggests the company wants to compete on workflow integration, not just financial tracking. - Leslie’s mix of clinical operations and data strategy experience gives Auxilius a leader who can speak to both sponsors and software buyers.

What's next: - Leslie will help guide product development and market expansion around investigator grant solutions. - Auxilius plans to continue expanding its platform capabilities while helping sponsors streamline trial execution. - The company is likely to use Leslie’s industry background to deepen relationships with clinical operations, finance and site stakeholders.

The bottom line: - Auxilius is adding a seasoned operator to turn investigator grant management into a more connected, data-driven part of clinical trial finance.